Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer

Carcinogenesis

Volumn 28, Issue 3, 2007, Pages 698-703

  Zhu, Yimin ^a,b   Lai, Maode ^b   Yang, Hushan ^a   Lin, Jie ^a   Huang, Maosheng ^a   Grossman, H Barton ^a   Dinney, Colin P ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUTAMINE; LYSINE; VALINE; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AMINO ACID SUBSTITUTION; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 34047127455     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl201     Document Type: Article

References (43)

1. Jemal,A., Murray,T., Ward,E., Samuels,A., Tiwari,R.C., Ghafoor,A., Feuer,E.J. and Thun,M.J. (2005) Cancer statistics, 2005. CA Cancer J. Clin., 55, 10-30.
2. Edwards,B.K., Brown,M.L., Wingo,P.A. et al. (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl Cancer Inst., 97, 1407-1427.
3. Zeegers,M.P., Tan,F.E., Dorant,E. and van Den Brandt,P.A. (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer, 89, 630-639.
4. Cohen,S.M., Shirai,T. and Steineck,G. (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J. Urol. Nephrol. (Suppl), 105-115.
5. Friedberg,E.C. (2001) How nucleotide excision repair protects against cancer. Nat. Rev. Cancer, 1, 22-33.
6. Wood,R.D., Mitchell,M., Sgouros,J. and Lindahl,T. (2001) Human DNA repair genes. Science, 291, 1284-1289.
7. Bonn,D. (1998) How DNA-repair pathways may affect cancer risk. Lancet, 351, 42.
8. Wei,Q., Cheng,L., Amos,C.I., Wang,L.E., Guo,Z., Hong,W.K. and Spitz,M.R. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
9. Sugasawa,K., Ng,J.M., Masutani,C., Iwai,S., van der Spek,P.J., Eker,A.P., Hanaoka,F., Bootsma,D. and Hoeijmakers,J.H. (1998) Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell, 2, 223-232.
10. Legerski,R. and Peterson,C. (1992) Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature, 359, 70-73.
11. Li,L., Peterson,C. and Legerski,R. (1996) Sequence of the mouse XPC cDNA and genomic structure of the human XPC gene. Nucleic Acids Res., 24, 1026-1028.
12. Masutani,C., Sugasawa,K., Yanagisawa,J. et al. (1994) Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. Embo J., 13, 1831-1843.
13. Khan,S.G., Metter,E.J., Tarone,R.E., Bohr,V.A., Grossman,L., Hedayati,M., Bale,S.J., Emmert,S. and Kraemer,K.H. (2000) A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis, 21, 1821-1825.
14. Khan,S.G., Muniz-Medina,V., Shahlavi,T., Baker,C.C., Inui,H., Ueda,T., Emmert,S., Schneider,T.D. and Kraemer,K.H. (2002) The human XPC DNA repair gene: Arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res., 30, 3624-3631.
15. Hu,Z., Wang,Y., Wang,X., Liang,G., Miao,X., Xu,Y., Tan,W., Wei,Q., Lin,D. and Shen,H. (2005) DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int. J. Cancer, 115, 478-483.
16. Qiao,Y., Spitz,M.R., Guo,Z., Mohammad,H., Lawrence,G., Kenneth,K.H. and Wei,Q. (2002) Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res., 509, 165-174.
17. Shen,H., Sturgis,E.M., Khan,S.G. et al. (2001) An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: A case-control study. Cancer Res., 61, 3321-3325.
18. Blankenburg,S., Konig,I.R., Moessner,R. et al. (2005) Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: A case-control study. Carcinogenesis, 26, 1085-1090.
19. Sanyal,S., Festa,F., Sakano,S., Zhang,Z., Steineck,G., Norming,U., Wijkstrom,H., Larsson,P., Kumar,R. and Hemminki,K. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-734.
20. Zhang,L., Zhang,Z. and Yan,W. (2005) Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin. Chim. Acta, 359, 150-155.
21. Marin,M.S., Lopez-Cima,M.F., Garcia-Castro,L., Pascual,T., Marron,M.G. and Tardon,A. (2004) Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev., 13, 1788-1793.
22. Sak,S.C., Barrett,J.H., Paul,A.B., Bishop,D.T. and Kiltie,A.E. (2005) The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J. Cancer, 92, 2262-2265.
23. Nelson,H.H., Kelsey,K.T., Mott,L.A. and Karagas,M.R. (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: Evidence of gene-environment interaction. Cancer Res., 62, 152-155.
24. Lee,G.Y., Jang,J.S., Lee,S.Y. et al. (2005) XPC polymorphisms and lung cancer risk. Int. J. Cancer, 115, 807-813.
25. Garcia-Closas,M., Malats,N., Real,F.X. et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 536-542.
26. Matullo,G., Guarrera,S., Sacerdote,C. et al. (2005) Polymorphisms/ haplotypes in DNA repair genes and smoking: A bladder cancer case-control study. Cancer Epidemiol. Biomarkers Prev., 14, 2569-2578.
27. Hao,B., Wang,H., Zhou,K. et al. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res., 64, 4378-4384.
28. Wu,X., Gu,J., Grossman,H.B. et al. (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
29. Wu,X., Zhao,H., Wei,Q., Amos,C.I., Zhang,K., Guo,Z., Qiao,Y., Hong,W.K. and Spitz,M.R. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509.
30. Montironi,R. and Lopez-Beltran,A. (2005) The 2004 WHO classification of bladder tumors: A summary and commentary. Int. J. Surg. Pathol., 13, 143-153.
31. Ryk,C., Kumar,R., Sanyal,S., de Verdier,P.J., Hemminki,K., Larsson,P., Steineck,G. and Hou,S.M. (2006) Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett., 241, 142-149.
32. Weiss,J.M., Weiss,N.S., Ulrich,C.M., Doherty,J.A., Voigt,L.F. and Chen,C. (2005) Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol. Biomarkers Prev., 14, 2524-2530.
33. Kuricova,M., Naccarati,A., Kumar,R et al. (2005) DNA repair and cyclin D1 polymorphisms and styrene-induced genotoxicity and immunotoxicity. Toxicol. Appl. Pharmacol., 207, 302-309.
34. Bowen,A.R., Hanks,A.N., Allen,S.M., Alexander,A., Diedrich,M.J. and Grossman,D. (2003) Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J. Invest. Dermatol., 120, 48-55.
35. Miller,K.L., Karagas,M.R., Kraft,P., Hunter,D.J., Catalano,P.J., Byler,S.H. and Nelson,H.H. (2006) XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis., 27, 1670-1675.
36. Mothersill,C., O'Malley,K., Murphy,D. and Seymour,C.B. (1997) Apoptosis and other effects of radiation in normal human urothelial cells. Radiat. Oncol. Investig., 5, 150-153.
37. Mothersill,C., Harney,J., Lyng,F., Cottell,D., Parsons,K., Murphy,D.M. and Seymour,C.B. (1995) Primary explants of human uroepithelium show an unusual response to low-dose irradiation with cobalt-60 gamma rays. Radiat. Res., 142, 181-187.
38. Mothersill,C.E., O'Malley,K.J., Murphy,D.M., Seymour,C.B., Lorimore,S.A. and Wright,E.G. (1999) Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation. Carcinogenesis, 20, 2273-2278.
39. Xu,J., Lowey,J., Wiklund,F. et al. (2005) The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 2563-2568.
40. Garcia-Closas,M., Malats,N., Silverman,D. et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-659.
41. Schabath,M.B., Delclos,G.L., Grossman,H.B., Wang,Y., Lerner,S.P., Chamberlain,R.M., Spitz,M.R. and Wu,X. (2005) Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 878-884.
42. Spitz,M.R., Wei,Q., Dong,Q., Amos,C.I. and Wu,X. (2003) Genetic susceptibility to lung cancer: The role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev., 12, 689-698.
43. Castelao,J.E., Yuan,J.M., Skipper,P.L., Tannenbaum,S.R., Gago-Dominguez,M., Crowder,J.S., Ross,R.K. and Yu,M.C. (2001) Gender- and smoking-related bladder cancer risk. J. Natl Cancer Inst., 93, 538-545.